Evidence map›Paper›PMID 33838090›Full record

ReviewJournal of pediatric endocrinology & metabolism : JPEM2021

Provocative growth hormone testing in children: how did we get here and where do we go now?

Camilia Kamoun, Colin Patrick Hawkes, Adda Grimberg

Open access · greenAbstract readReview
In one paragraph

Review in Journal of pediatric endocrinology & metabolism : JPEM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Compounding and stability studies of liquid oral formulations of beta-blockers (bisoprolol, betaxolol, and nadolol) for paediatric patients.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Novel therapies for growth disorders.European journal of pediatrics · 2024
    Review
  17. Growth Hormone Treatment for Non-GHD Disorders: Excitement Tempered by Biology.The Journal of clinical endocrinology and metabolism · 2024
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Camilia KamounDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Colin Patrick HawkesDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Adda GrimbergDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
University of Pennsylvania · USChildren's Hospital of Philadelphia · US

Funding

Translational Research Training in Pediatric Diabetes & EndocrinologyT32DK063688 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI LORRAINE E LEVITT KATZ, ANDREA Bridget KELLY · 2002 to 2026
$5.4M
A new paradigm of short stature: Incorporating parent and youth characteristics into understanding GH-related decision making and trajectories of quality of life and self-esteemR01HD097129 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI GRIMBERG, ADDA, MILLER, VICTORIA ALLISON · 2019 to 2023
$2.4M
NICHD NIH HHS R01 HD097129NIDDK NIH HHS T32 DK063688
6 · The paper itself

Abstract

objectivesProvocative growth hormone (GH) tests are widely used for diagnosing pediatric GH deficiency (GHD). A thorough understanding of the evidence behind commonly used interpretations and the limitations of these tests is important for improving clinical practice. CONTENT: To place current practice into a historical context, the supporting evidence behind the use of provocative GH tests is presented. By reviewing GH measurement techniques and examining the early data supporting the most common tests and later studies that compared provocative agents to establish reference ranges, the low sensitivity and specificity of these tests become readily apparent. Studies that assess the effects of patient factors, such as obesity and sex steroids, on GH testing further bring the appropriateness of commonly used cutoffs for diagnosing GHD into question. SUMMARY AND OUTLOOK: Despite the widely recognized poor performance of provocative GH tests in distinguishing GH sufficiency from deficiency, limited progress has been made in improving them. New diagnostic modalities are needed, but until they become available, clinicians can improve the clinical application of provocative GH tests by taking into account the multiple factors that influence their results.

Indexed as

ChildDiagnostic Techniques and ProceduresGrowth DisordersHuman Growth HormoneHumansHuman Growth Hormonechildrengrowth hormone assaygrowth hormone deficiencygrowth hormone stimulation testsprovocative growth hormone testing

Identifiers

PMID33838090
PMCPMC8165022
OpenAlexW3152411155

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.